| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8725486 | Clinics and Research in Hepatology and Gastroenterology | 2018 | 10 Pages |
Abstract
Therefore, we demonstrated for the first time that SNORD76 may function as a novel tumor promoter in HCC and may serve as a promising prognostic biomarker in patients with HCC.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Long Wu, Lei Chang, Haitao Wang, Weijie Ma, Qin Peng, Yufeng Yuan,